Features of the pathogenesis, epidemiology, diagnostics, approaches to the treatment and prevention of small pox, the current state of the problem in Ukraine and the world
Abstract
Introduction. Monkey pox is an anthropozoonous disease caused by orthopoxvirus, characterized by fever, general intoxication and skin rash, in some cases it can lead to fatal consequences; an infectious disease covered by international health regulations (IHR). The causative agent of the disease is classified as a biological agent - agent of a biological weapon. Most of the monkeypox cases associated with the 2022 outbreak are in the Western Hemisphere. Purpose: study of data on etiological, pathogenetic, epidemiological aspects, modern approaches to the diagnosis, treatment and prevention of monkeypox, the state of the problem in Ukraine and the world. Materials and methods: to perform the task, a review of publications was conducted in electronic databases of medical publications PubMed Medline of the US National Library of Medicine (NLM), Cochrane Database of Systematic Reviews, CDC (Centers for Disease Control and Prevention) website of the federal agency of the Ministry of Health USA. Results: The second generation ACAM2000 and third generation JYNNEOS™ monkeypox vaccines are currently available. Both vaccines are able to create immunity against monkeypox. Post-exposure vaccination can help prevent or reduce the severity of monkeypox. ACAM2000 is a single-dose vaccinia vaccine licensed by the FDA for the prevention of smallpox. Full immunity is achieved 4 weeks after vaccination. FDA expanded access to investigational protocol allows use of ACAM2000 for monkeypox immunization during an outbreak. The immunogenicity and protective efficacy of ACAM2000 is equivalent to that of the first generation Dryvax® smallpox vaccine. Smallpox vaccine virus is used as a live attenuated virus in the smallpox vaccine. Cases of encephalitis and Guillain-Barré syndrome following smallpox vaccination show that the incidence varies not only from place to place, but also from year to year in the same place. For the purposes of containment of the outbreak, prevention to reduce the risk of transmission from person to person, immediate detection of new cases and surveillance measures are necessary. Health care workers who provide care to patients with suspected or confirmed monkeypox who work with their specimens should use standard precautions to control infection. Specimens taken from animals or humans suspected of having monkeypox should be handled in equipped laboratories by trained personnel. According to WHO recommendations, samples taken from patients should be appropriately labeled, prepared for transportation using triple packaging. To prevent the further spread of monkeypox through the animal trade, captive animals potentially infected with smallpox must be isolated from other animals and quarantined for 30 days. Conclusions: 1.The monkeypox virus, which used to be endemic to certain regions of Africa, is now a global concern, with cases increasingly being reported in regions of the Western Hemisphere. 2. In connection with the fact that transmission from person to person most often occurs through airborne droplets or through direct contact with the mucous secretions of an infected person, social distancing and contact tracing are advisable. 3. In the last 6 months, cases of monkeypox have been confirmed among middle-aged people, which can be explained by the loss of cross-immunity from the smallpox vaccine. 4. The monkeypox virus multiplies in the cytoplasm and matures, creating primary viremia. Manifestations of a severe course of monkeypox are bronchopneumonia, respiratory distress syndrome, encephalitis, chorioretinal scars on the retina, etc. To minimize the risk of complications, it is advisable to provide timely treatment. 5. Medical organizations around the world are focused on understanding how cases of monkeypox are increasingly occurring in countries in the Western Hemisphere. 6. The study of etiotropic methods of treating monkey pox is promising.
Downloads
References
Spisok tovarіv podvіinogo vikoristannya, shcho mozhut' buti vikoristanі u stvorennі bakterіologіchnoї (bіologіchnoї) ta toksinnoї zbroї, zatverdzhenii postanovoyu Kabіnetu Mіnіstrіv Ukraїni vіd 28.01.2004 r. № 86 (u redaktsії postanovi Kabіnetu Mіnіstrіv Ukraїni vіd 05.04.2012). https://zakon.rada.gov.ua/go/86-2004-%D0%BF. [in Ukrainian].
Reed KD, Melski JW, Graham MB [et al.] : The detection of monkeypox in humans in the Western Hemisphere. N Engl. J. Med. 2004, 350:342-50. doi: 10.1056/NEJMoa032299. PMID: 14736926.
Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb. Mortal. Wkly Rep. 2003 Jul 11;52(27):642-6. PMID: 12855947.
Minhaj FS, Ogale YP, Whitehill F, et al. Monkeypox Outbreak — Nine States, May 2022. MMWR Morb. Mortal. Wkly Rep 2022;71:764–769. DOI: http://dx.doi.org/10.15585/mmwr.mm7123e1.
Okoh, M., & Nwachukwu, K. C. (2022). A Virulent Disease Called Monkeypox: A Case Report of Countries in Africa Where The Disease is Endemic. Indo Global Journal of Pharmaceutical Sciences, 12, 237–244. https://doi.org/10.35652/IGJPS.2022.12030.
https://www.ukr.net/news/details/health/93422335.
World Health Organization (17 June 2022). Disease Outbreak News; Multi-country monkeypox outbreak in non-endemic countries: Update. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON393.
Fauquet CM. Taxonomy, Classification and Nomenclature of Viruses. Encyclopedia of Virology. 2008:9–23. doi: 10.1016/B978-012374410-4.00509-4. Epubю 2008 Jul 30. PMCID: PMC7150148.
Hagan LM, Beeson A, Hughes S, et al. Monkeypox Case Investigation — Cook County Jail, Chicago, Illinois,
July–August 2022. MMWR Morb. Mortal. Wkly Rep 2022;71:1271–1277. DOI: http://dx.doi.org/10.15585/mmwr.mm7140e2.
Durski KN, McCollum AM, Nakazawa Y, et al. Emergence of Monkeypox — West and Central Africa, 1970–2017. MMWR Morb Mortal Wkly Rep 2018;67:306–310. DOI: http://dx.doi.org/10.15585/mmwr.mm6710a5.
Yinka-Ogunleye A, Aruna O, Ogoina D, [et al.]. Reemergence of Human Monkeypox in Nigeria, 2017. Emerg Infect Dis. 2018 Jun;24(6):1149-1151. doi: 10.3201/eid2406.180017. Epub 2018 Jun 17. PMID: 29619921; PMCID: PMC6004876.
Rao AK, Petersen BW, Whitehill F, et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:734–742. DOI: http://dx.doi.org/10.15585/mmwr.mm7122e1.
Rao AK, Schulte J, Chen T, et al. Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep 2022;71:509–516. DOI: http://dx.doi.org/10.15585/mmwr.mm7114a1external icon.
Eteng WE, Mandra A, Doty J, Yinka-Ogunleye A, [et al.]. Notes from the Field: Responding to an Outbreak of Monkeypox Using the One Health Approach - Nigeria, 2017-2018. MMWR Morb Mortal Wkly Rep. 2018 Sep 21;67(37):1040-1041. doi: 10.15585/mmwr.mm6737a5. PMID: 30235181; PMCID: PMC6147416.
Doshi RH, Guagliardo SAJ, Dzabatou-Babeaux A. [et al.]. Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo, 2017. Emerg Infect Dis. 2018 Jun;24(6):1158-1160. doi: 10.3201/eid2406.180248. PMID: 29774865; PMCID: PMC6004878.
Titanji BK, Tegomoh B, Nematollahi S, Konomos M, Kulkarni PA. Monkeypox: A Contemporary Review for Healthcare Professionals. Open Forum Infect Dis. 2022 Jun 23;9(7):ofac310. doi: 10.1093/ofid/ofac310. PMID: 35891689; PMCID: PMC9307103.
Langohr IM, Stevenson GW, Thacker HL, Regnery RL. Extensive lesions of monkeypox in a prairie dog (Cynomys sp). Vet Pathol. 2004 Nov;41(6):702-7. doi: 10.1354/vp.41-6-702. PMID: 15557083.
Centers for Disease Control and Prevention (CDC). Multistate outbreak of monkeypox--Illinois, Indiana, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep. 2003 Jun 13;52(23):537-40. PMID: 12803191.
Reynolds MG, Davidson WB, Curns AT. [et al.]. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg. Infect. Dis. 2007 Sep;13(9):1332-9. doi: 10.3201/eid1309.070175. PMID: 18252104; PMCID: PMC2857287.
Kaler J, Hussain A, Flores G, et al. (July 03, 2022). Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation. Cureus 14(7): e26531. doi:10.7759/cureus.26531.
Stanford MM, McFadden G, Karupiah G, Chaudhri G. Immunopathogenesis of poxvirus infections: forecasting the impending storm. Immunol Cell Biol. 2007 Feb-Mar;85(2):93-102. doi: 10.1038/sj.icb.7100033. Epub 2007 Jan 16. PMID: 17228320.
Hudson PN, Self J, Weiss S, Braden Z, Xiao Y, Girgis NM, Emerson G, Hughes C, Sammons SA, Isaacs SN, Damon IK, Olson VA. Elucidating the role of the complement control protein in monkeypox pathogenicity. PLoS One. 2012;7(4):e35086. doi: 10.1371/journal.pone.0035086. Epub 2012 Apr 9. PMID: 22496894; PMCID: PMC3322148.
McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014 Jan;58(2):260-7. doi: 10.1093/cid/cit703. Epub 2013 Oct 24. Erratum in: Clin Infect Dis. 2014 Jun;58(12):1792. PMID: 24158414.
Shafaati M, Zandi M. Monkeypox virus neurological manifestations in comparison to other orthopoxviruses. Travel Med Infect Dis. 2022 Sep-Oct;49:102414. doi: 10.1016/j.tmaid.2022.102414. Epub 2022 Aug 2. PMID: 35926767.
McEntire CRS, Song KW, McInnis RP. [et al.]. Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases. Front Neurol. 2021 Feb 22;12:634827. doi: 10.3389/fneur.2021.634827. PMID: 33692745; PMCID: PMC7937722.
Huhn GD, Bauer AM, Yorita K. [et al.]. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005 Dec 15;41(12):1742-51. doi: 10.1086/498115. Epub 2005 Nov 11. PMID: 16288398.
Moss B. Poxvirus cell entry: how many proteins does it take? Viruses. 2012 May;4(5):688-707. doi: 10.3390/v4050688. Epub 2012 Apr 27. PMID: 22754644; PMCID: PMC3386626.
Moss B. Poxvirus DNA replication. Cold Spring Harb Perspect Biol. 2013 Sep 1;5(9):a010199. doi: 10.1101/cshperspect.a010199. PMID: 23838441; PMCID: PMC3753712.
Olivia Carulei, Nicola Douglass, Anna-Lise Williamson. Comparative analysis of avian poxvirus genomes, including a novel poxvirus from lesser flamingos (Phoenicopterus minor), highlights the lack of conservation of the central region. BMC Genomics, 2017, № 1. https://doi.org/10.1186/s12864-017-4315-0.
Tyler KL. Emerging viral infections of the central nervous system: part 2. Arch Neurol. 2009 Sep;66(9):1065-74. doi: 10.1001/archneurol.2009.189. PMID: 19752295; PMCID: PMC2876734.
Farahat, R.A., Abdelaal, A., Shah, J. et al. Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic?. Ann. Clin. Microbiol. Antimicrob. 21, 26 (2022). https://doi.org/10.1186/s12941-022-00518-2.
Lane H. Clifford, Fauci Anthony S.. (2022). Monkeypox — Past as Prologue. N Engl J Med 387:8, 2022; 749-750. 387:579-581 DOI: 10.1056/NEJMp2210125.
De Clercq E. Cidofovir in the treatment of poxvirus infections. Antiviral Res. 2002 Jul;55(1):1-13. doi: 10.1016/s0166-3542(02)00008-6. PMID: 12076747.
Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries —
April–June 2022. N Engl J Med. DOI: 10.1056/NEJMoa2207323.
Chan-Tack KM, Harrington PR, Choi SY, Myers L. [et al.]. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox. Lancet Infect Dis. 2019 Jun;19(6):e221-e224. doi: 10.1016/S1473-3099(18)30788-6. Epub 2019 Mar 7. PMID: 30853252.
Bunge EM, Hoet B, Chen L, Lienert F,, et al. (2022) The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Negl. Trop. Dis. 16(2): e0010141. https://doi.org/10.1371/journal.pntd.0010141.
Karem KL, Reynolds M, Hughes C, Braden Z, [et al.]. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol. 2007 Oct;14(10):1318-27. doi: 10.1128/CVI.00148-07. Epub. 2007 Aug. 22. PMID: 17715329; PMCID: PMC2168110.
CDC. Monkeypox prevention. Available at: https:// www.cdc.gov/poxvirus/monkeypox/prevention. html#:~:text=Avoid%20contact%20with%20animals%20 that,be%20at%20risk%20for%20infection. Accessed May 21, 2022.